People enter a pharmacy next to a sign promoting flu shots in New York January 10, 2013. (Photo: REUTERS) |
The two-dose vaccine employs the same mRNA technology used in the COVID-19 shots developed by Pfizer with BioNTech, and by Moderna.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley at the University of Pennsylvania said in a statement.